Recent Publications on Radioimmunotherapy: |  |
Aiming at a Curative Strategy for Follicular Lymphoma.
Follicular lymphoma is often managed as an incurable disease. However, a...
Direct Link | 30th August, 2008
| Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital,
|
Thyroid cancer: The impact of emerging technologies on clinical practice guidelines.
Clinical practice guidelines are available for the evaluation and...
Direct Link | 30th August, 2008
| Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School
|
The Effects of Adjuvant Experimental Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy on Intestinal and Abdominal Healing after Cytoreductive Surgery for Peritoneal Carcinomatosis in the Rat.
BACKGROUND: Cytoreductive surgery (CS) followed by hyperthermic...
Direct Link | 21st August, 2008
| Department of Surgery, Radboud University Nijmegen Medical Centre,
|
Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.
PURPOSE: Studies herein explore paclitaxel enhancement of the therapeutic...
Direct Link | 21st August, 2008
| Division of Hematology-Oncology, Georgetown University Hospital,
|
| Management of relapsed diffuse large B-cell lymphoma.
| 19th August, 2008
| Section of Hematology/Oncology, Department of Medicine, The University of
|
Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate.
Our goals in this study were to determine whether (111)In-trastuzumab...
Direct Link | 16th August, 2008
| Leslie Dan Faculty of Pharmacy, Department of Pharmaceutical Sciences,
|
Drug-Resistant AML Cells and Primary AML Specimens Are Killed by 111In-Anti-CD33 Monoclonal Antibodies Modified with Nuclear Localizing Peptide Sequences.
Multidrug resistance (MDR) is a major challenge to the successful...
Direct Link | 16th August, 2008
| Department of Pharmaceutical Sciences, University of Toronto, Toronto,
|
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy.
Radioimmunotherapy (RIT) is a method for selectively delivering...
Direct Link | 15th August, 2008
| Division of Hematology and Oncology, Internal Medicine, University of
|
Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.
PURPOSE: Studies herein explore paclitaxel enhancement of the therapeutic...
Direct Link | 14th August, 2008
| Radioimmune and Inorganic Chemistry Section, Radiation Oncology Branch,
|
Fractionated 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice.
Dose fractionation has been proposed as a method to improve the...
Direct Link | 7th August, 2008
| Cancer Research UK, Targeting and Imaging Group, Department of Oncology,
|
Radiation therapy with tositumomab (B1) anti-CD20 monoclonal antibody initiates extracellular signal-regulated kinase/mitogen-activated protein kinase-dependent cell death that overcomes resistance to apoptosis.
PURPOSE: The use of targeted radiation therapy (RT) in conjunction with...
Direct Link | 5th August, 2008
| School of Cancer and Imaging Sciences, CRUK Paterson Institute for Cancer
|
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons.
To improve radioimmunotherapy with Auger electron emitters, we assessed...
Direct Link | 1st August, 2008
| Direction de la Radioprotection de l'Homme, Institut de Radioprotection et
|
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study.
Radioimmunotherapy with Yttrium-90 ((90)Y) ibritumomab tiuxetan (IT) has...
Direct Link | 29th July, 2008
| Clinic for Nuclear Medicine, Charite-Universitatsmedizin Berlin, Berlin,
|
Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review.
Multicenter, retrospective study of standard-dose RIT in eight heavily...
Direct Link | 29th July, 2008
| Centre Antoine Lacassagne, Nice, France.
|
New insights into the mechanisms of action of radioimmunotherapy in lymphoma.
The exquisite sensitivity of haematological malignancies to targeted...
Direct Link | 23rd July, 2008
| School of Cancer and Imaging Sciences, Paterson Institute for Cancer
|
